139 related articles for article (PubMed ID: 16828742)
1. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry.
Liang Y; Fang M; Li J; Liu CB; Rudd JA; Kung HF; Yew DT
Exp Mol Pathol; 2006 Oct; 81(2):176-80. PubMed ID: 16828742
[TBL] [Abstract][Full Text] [Related]
2. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
3. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
4. [Identification of colorectal cancer using proteomic patterns in serum].
Zhao G; Gao CF; Song GY; Li DH; Wang XL
Ai Zheng; 2004 Jun; 23(6):614-8. PubMed ID: 15191657
[TBL] [Abstract][Full Text] [Related]
5. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
6. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].
Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of gastric cancer using decision tree classification of mass spectral data.
Su Y; Shen J; Qian H; Ma H; Ji J; Ma H; Ma L; Zhang W; Meng L; Li Z; Wu J; Jin G; Zhang J; Shou C
Cancer Sci; 2007 Jan; 98(1):37-43. PubMed ID: 17052262
[TBL] [Abstract][Full Text] [Related]
8. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
9. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
10. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry].
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
12. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
13. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
14. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; Hommann M; Richter KK; Daffner W; Settmacher U; Claussen U; von Eggeling F
J Proteome Res; 2005; 4(5):1799-804. PubMed ID: 16212435
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
16. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
17. SELDI-TOF serum proteomics and breast cancer: which perspective?
Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
[TBL] [Abstract][Full Text] [Related]
18. Identification and confirmation of increased fibrinopeptide a serum protein levels in gastric cancer sera by magnet bead assisted MALDI-TOF mass spectrometry.
Ebert MP; Niemeyer D; Deininger SO; Wex T; Knippig C; Hoffmann J; Sauer J; Albrecht W; Malfertheiner P; Röcken C
J Proteome Res; 2006 Sep; 5(9):2152-8. PubMed ID: 16944926
[TBL] [Abstract][Full Text] [Related]
19. [Identification of biomarkers in the serum of the patients with poorly differentiated gastric cancer].
Li W; Liu BY; Li JF; Chen XH; Hao JH; Cai Q; Gu QL; Zhu ZG; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):253-6. PubMed ID: 16721691
[TBL] [Abstract][Full Text] [Related]
20. Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins.
Kojima T; Yoshikawa K; Saga S; Yamada T; Kure S; Matsui T; Uemura T; Fujimitsu Y; Sakakibara M; Kodera Y; Kojima H
J Surg Res; 2009 Jul; 155(1):13-7. PubMed ID: 19394641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]